Table of Content

Executive Summary

1 Product Definition
1.1 Inclusion and Exclusion

2 Market Scope
2.1 Scope of the Study
2.2 Key Questions Answered in the Report
2.3 Global Genomic Data Analysis and Interpretation Market: Research Methodology

3 Research Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling

4 Market Overview
4.1 Market Definition
4.2 Market Footprint and Growth Potential, $Million, 2019-2030
4.3 COVID-19 Impact on Global Genomic Analysis and Interpretation Market

5 Industry Analysis
5.1 Overview
5.2 Legal Requirements and Framework in U.S.
5.3 Legal Requirements and Framework in Europe
5.4 Legal Requirements and Framework in Asia-Pacific
5.4.1 China
5.4.2 Japan

6 Market Dynamics
6.1 Overview
6.2 Iceberg Analysis – Global Genomic Data Analysis and Interpretation Market
6.3 Impact Analysis
6.4 Market Drivers
6.4.1 Decreasing Cost of Sequencing
6.4.2 Global Increase in Cancer Prevalence
6.4.3 Increasing Number of Population Genomics Initiatives
6.5 Market Restraints
6.5.1 Lack of High Complexity Genomic Testing Centers in High Potential Markets
6.5.2 Challenges Pertaining to Genomic Data Storage
6.5.3 Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities
6.6 Market Opportunities
6.6.1 Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
6.6.2 Novel Diagnostic Applications

7 Competitive Landscape
7.1 Product Launch and Upgrades
7.2 Synergistic Activities
7.3 Acquisitions
7.4 Market Share Analysis, by Company, 2018-2019
7.5 Growth Share Analysis
7.5.1 Growth Share Analysis (by Company)
7.5.2 Growth Share Analysis (by Application)

8 Global Genomic Data Analysis and Interpretation Market (by Product Type)
8.1 Overview
8.2 Software
8.3 Services
8.3.1 Licenses
8.3.2 Maintenance

9 Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)
9.1 Overview
9.2 Next-Generation Sequencing (NGS)
9.3 Polymerase Chain Reaction (PCR)
9.4 Microarray
9.5 Other Genomic Platforms

10 Global Genomic Data Analysis and Interpretation Market (by Application)
10.1 Overview
10.2 Research Applications
10.2.1 Omics-Data Analysis
10.2.1.1 Transcriptomics
10.2.1.2 Microbiomics
10.2.1.3 Proteomics
10.2.1.4 Other Omics-Data Analysis
10.2.2 Population Genomics
10.2.3 Annotation and Gene Expression
10.2.4 Other Research Applications
10.3 Clinical Applications
10.3.1 Oncology
10.3.2 Rare Diseases
10.3.3 Infectious Diseases
10.3.4 Sexual and Reproductive Health
10.3.5 Other Clinical Applications

11 Global Genomic Data Analysis and Interpretation Market (by End User)
11.1 Overview
11.2 Research and Academic Institutions
11.3 Biotechnology and Biopharmaceutical Companies
11.4 Hospitals and Diagnostic Laboratories
11.5 Contract Research Organizations
11.6 Forensic Laboratories
11.7 Other End Users

12 Global Genomic Data Analysis and Interpretation Market (by Region)
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.2.3 North America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 Netherlands
12.3.7 Rest-of-Europe
12.3.8 Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Rest-of-Asia-Pacific
12.4.7 Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.5 Latin America
12.5.1 Brazil
12.5.2 Mexico
12.5.3 Rest-of-Latin-America
12.5.4 Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.6 Rest-of-the-World

13 Company Profiles
13.1 Overview
13.2 10x Genomics, Inc.
13.2.1 Company Overview
13.2.2 Role of 10x Genomics, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.2.3 Financials
13.2.4 Key Insights About Financial Health of the Company
13.2.5 SWOT Analysis
13.3 Agilent Technologies, Inc.
13.3.1 Company Overview
13.3.2 Role of Agilent Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.3.3 Financials
13.3.4 Key Insights About Financial Health of the Company
13.3.5 SWOT Analysis
13.4 ASURAGEN, INC.
13.4.1 Company Overview
13.4.2 Role of ASURAGEN, INC. in the Global Genomic Data Analysis and Interpretation Market
13.4.3 SWOT Analysis
13.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd
13.5.1 Company Overview
13.5.2 Role of Beijing Genomics Institute (BGI) Genomics Co., Ltd in the Global Genomic Data Analysis and Interpretation Market
13.5.3 SWOT Analysis
13.6 Bio-Rad Laboratories, Inc.
13.6.1 Company Overview
13.6.2 Role of Bio-Rad Laboratories, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.6.3 Financials
13.6.4 Key Insights About Financial Health of the Company
13.6.5 SWOT Analysis
13.7 DNASTAR
13.7.1 Company Overview
13.7.2 Roles of DNASTAR in the Global Genomic Data Analysis and Interpretation Market
13.7.3 SWOT Analysis
13.8 F. Hoffmann-La Roche Ltd
13.8.1 Company Overview
13.8.2 Role of F. Hoffmann-La Roche Ltd. in the Global Genomic Data Analysis and Interpretation Market
13.8.3 Financials
13.8.4 Key Insights About Financial Health of the Company
13.8.5 SWOT Analysis
13.9 Golden Helix, Inc.
13.9.1 Company Overview
13.9.2 Role of Golden Helix, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.9.3 SWOT Analysis
13.1 Illumina, Inc.
13.10.1 Company Overview
13.10.2 Role of Illumina, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.10.3 Financials
13.10.4 Key Insights About Financial Health of the Company
13.10.5 SWOT Analysis
13.11 Oxford Nanopore Technologies, Inc.
13.11.1 Company Overview
13.11.2 Role of Oxford Nanopore Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.11.3 SWOT Analysis
13.12 Pacific Biosciences of California, Inc.
13.12.1 Company Overview
13.12.2 Role of Pacific Biosciences of California, Inc. in the Global Genomic Data Analysis and Interpretation Market
13.12.3 Financials
13.12.4 Key Insights About Financial Health of the Company
13.12.5 SWOT Analysis
13.13 Partek Inc.
13.13.1 Company Overview
13.13.2 Role of Partek Inc. in the Global Genomic Data Analysis and Interpretation Market
13.13.3 SWOT Analysis
13.14 QIAGEN N.V
13.14.1 Company Overview
13.14.2 Role of QIAGEN N.V. in the Global Genomic Data Analysis and Interpretation Market
13.14.3 Financials
13.14.4 Key Insights About Financial Health of the Company
13.14.5 SWOT Analysis
13.15 SoftGenetics, LLC.
13.15.1 Company Overview
13.15.2 Role of SoftGenetics, LLC in the Global Genomic Data Analysis and Interpretation Market
13.15.3 SWOT Analysis
13.16 Thermo Fisher Scientific Inc.
13.16.1 Company Overview
13.16.2 Role of Thermo Fisher Scientific Inc. in the Global Genomic Data Analysis and Interpretation Market
13.16.3 Financials
13.16.4 Key Insights About Financial Health of the Company
13.16.5 SWOT Analysis
 



List of Tables


Table 6.1: Likert Scale
Table 6.2: Impact Analysis of Market Drivers
Table 6.3: Impact Analysis of Market Restraints
Table 8.1: Examples of Software in the Global Genomic Data Analysis and Interpretation Market

List of Figures


Figure 1: Annual NIH Funding in Human Genomics Research, FY2013-FY2018
Figure 2: Impact Analysis of Market Drivers and Market Challenges on Global Genomic Data Analysis and Interpretation Market
Figure 3: Global Genomic Data Analysis and Interpretation Market (by Product), $Million, 2019 vs. 2030
Figure 4: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), $Million, 2019 vs. 2030
Figure 5: Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019 vs. 2030
Figure 6: Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019 vs. 2030
Figure 7: Global Genomic Data Analysis and Interpretation Market Snapshot
Figure 2.1: Global Genomics Data Analysis and Interpretation, Market Segmentation
Figure 2.2: Global Genomic Data Analysis and Interpretation Market: Methodology
Figure 3.1: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.2: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 4.2: Global Genomic Data Analysis and Interpretation Market: COVID-19 Impact
Figure 6.1: Iceberg Analysis – Global Genomic Data Analysis and Interpretation Market
Figure 6.2: Decreasing Cost and Increasing Output (TB) of Genome Sequencing, 2009-2025
Figure 6.3: Global Cancer Burden, 2018
Figure 7.1: Share of Key Developments and Strategies, January 2017-November 2020
Figure 7.2: Share of Product Launch and Upgrades (by Company), January 2017–November 2020
Figure 7.3: Share of Synergistic Activities (by Company), January 2017- November 2020
Figure 7.4: Share of Acquisitions (by Company), January 2017-November 2020
Figure 7.5: Market Share Analysis for Global Genomic Data Analysis and Interpretation Market, 2018 and 2019
Figure 7.6: Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Company), 2019
Figure 7.7: Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Application), 2018-2019
Figure 8.1: Global Genomic Data Analysis and Interpretation Market (by Product Type)
Figure 8.2: Global Genomic Data Analysis and Interpretation Market (by Product Type), 2019 and 2030
Figure 8.3: Global Genomic Data Analysis and Interpretation Market (Software), $Million, 2019-2030
Figure 8.4: Global Genomic Data Analysis and Interpretation Market (by Services), 2019 and 2030
Figure 8.5: Global Genomic Data Analysis and Interpretation Market (by Services), $Million, 2019-2030
Figure 8.6: Global Genomic Data Analysis and Interpretation Market (Licenses), $Million, 2019-2030
Figure 8.7: Global Genomic Data Analysis and Interpretation Market (Maintenance), $Million, 2019-2030
Figure 9.1: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)
Figure 9.2: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), 2019 and 2030
Figure 9.3: Primary Data Analysis in NGS
Figure 9.4: Secondary Data Analysis in NGS
Figure 9.5: Tertiary Data Analysis in NGS
Figure 9.6: Global Genomic Data Analysis and Interpretation Market (NGS), $Million, 2019-2030
Figure 9.7: Global Genomic Data Analysis and Interpretation Market (PCR), $Million, 2019-2030
Figure 9.8: Global Genomic Data Analysis and Interpretation Market (Microarray), $Million, 2019-2030
Figure 9.9: Global Genomic Data Analysis and Interpretation Market (Other Genomic Platforms), $Million, 2019-2030
Figure 10.1: Global Genomic Data Analysis and Interpretation Market (by Application)
Figure 10.2: Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019-2030
Figure 10.3: Global Genomic Data Analysis and Interpretation Market (by Research Applications), $Million, 2019-2030
Figure 10.4: Global Genomic Data Analysis and Interpretation Market (by Omics-Data Analysis), $Million, 2019-2030
Figure 10.5: Global Genomic Data Analysis and Interpretation Market (Transcriptomics), $Million, 2019-2030
Figure 10.6: Global Genomic Data Analysis and Interpretation Market (Microbiomics), $Million, 2019-2030
Figure 10.7: Global Genomic Data Analysis and Interpretation Market (Proteomics), $Million, 2019-2030
Figure 10.8: Global Genomic Data Analysis and Interpretation Market (Other Omics-Data Analysis), $Million, 2019-2030
Figure 10.9: Global Genomic Data Analysis and Interpretation Market (Population Genomics), $Million, 2019-2030
Figure 10.10: Global Genomic Data Analysis and Interpretation Market (Annotation and Gene Expression), $Million, 2019-2030
Figure 10.11: Global Genomic Data Analysis and Interpretation Market (Other Research Applications), $Million, 2019-2030
Figure 10.12: Global Genomic Data Analysis and Interpretation Market (by Clinical Application), 2019 and 2030
Figure 10.13: Global Genomic Data Analysis and Interpretation Market (Oncology), $Million, 2019-2030
Figure 10.14: Global Genomic Data Analysis and Interpretation Market (Rare Diseases), $Million, 2019-2030
Figure 10.15: Global Genomic Data Analysis and Interpretation Market (Infectious Diseases), $Million, 2019-2030
Figure 10.16: Global Genomic Data Analysis and Interpretation Market (Sexual and Reproductive Health), $Million, 2019-2030
Figure 10.17: Global Genomic Data Analysis and Interpretation Market (Other Clinical Applications), $Million, 2019-2030
Figure 11.1: Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019-2030
Figure 11.2: Global Genomic Data Analysis and Interpretation Market (Research and Academic Institutions), $Million, 2019-2030
Figure 11.3: Global Genomic Data Analysis and Interpretation Market (Biotechnology and Pharmaceutical Companies), $Million, 2019-2030
Figure 11.4: Global Genomic Data Analysis and Interpretation Market (Hospitals and Diagnostic Laboratories), $Million, 2019-2030
Figure 11.5: Global Genomic Data Analysis and Interpretation Market (Contract Research Organizations), $Million, 2019-2030
Figure 11.6: Global Genomic Data Analysis and Interpretation Market (Forensic Laboratories), $Million, 2019-2030
Figure 11.7: Global Genomic Data Analysis and Interpretation Market (Other End Users), $Million, 2019-2030
Figure 12.1: Global Genomic Data Analysis and Interpretation Market (by Region), $Million, 2019-2030
Figure 12.2: Global Genomic Data Analysis and Interpretation Market (by Region), 2019-2030
Figure 12.3: North America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.4: North America: Market Dynamics
Figure 12.5: North America Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.6: U.S. Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.7: Canada Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.8: North America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.9: Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.10: Europe: Market Dynamics
Figure 12.11: Europe Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.12: Germany Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.13: U.K. Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.14: France Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.15: Italy Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.16: Spain Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.17: Netherlands Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.18: Rest-of-Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.19: Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.20: Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.21: APAC: Market Dynamics
Figure 12.22: APAC Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.23: China Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.24: Japan Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.25: India Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.26: Australia Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.27: South Korea Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.28: Rest-of-Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.29: Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.30: Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.31: Latin America: Market Dynamics
Figure 12.32: Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.33: Brazil Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.34: Mexico Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.35: Rest-of-Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.36: Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.37: RoW Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 13.1: Total Number of Companies Profiled
Figure 13.2: 10x Genomics, Inc.: Overall Product Portfolio
Figure 13.3: 10x Genomics, Inc.: Overall Financials, 2017-2019
Figure 13.4: 10x Genomics, Inc.: Revenue (by Segment), 2017-2019
Figure 13.5: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
Figure 13.6: 10x Genomics, Inc. R&D Expenditure, 2017-2019
Figure 13.7: 10x Genomics, Inc.: SWOT Analysis
Figure 13.8: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 13.9: Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 13.10: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
Figure 13.11: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 13.12: Agilent Technologies, Inc. R&D Expenditure, 2017-2019
Figure 13.13: Agilent Technologies, Inc.: SWOT Analysis
Figure 13.14: ASURAGEN, INC.: Overall Product Portfolio
Figure 13.15: ASURAGEN, INC.: SWOT Analysis
Figure 13.16: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Product Portfolio
Figure 13.17: Beijing Genomics Institute (BGI) Genomics Co., Ltd.: SWOT Analysis
Figure 13.18: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
Figure 13.19: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 13.20: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 13.21: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 13.22: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 13.23: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 13.24: DNASTAR: Overall Product Portfolio
Figure 13.25: DNASTAR: SWOT Analysis
Figure 13.26: F. Hoffmann-La Roche Ltd.: Overall Product Portfolio
Figure 13.27: F. Hoffmann-La Roche Ltd.: Overall Financials, 2017-2019
Figure 13.28: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), 2017-2019
Figure 13.29: F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics), 2017-2019
Figure 13.30: F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2017-2019
Figure 13.31: F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2017-2019
Figure 13.32: F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 13.33: Golden Helix, Inc.: Product Portfolio
Figure 13.34: Golden Helix, Inc.: SWOT Analysis
Figure 13.35: Illumina, Inc.: Overall Product Portfolio
Figure 13.36: Illumina, Inc.: Overall Financials, 2017-2019
Figure 13.37: Illumina, Inc.: Revenue (by Segment), 2017-2019
Figure 13.38: Illumina, Inc.: Revenue (by Region), 2017-2020
Figure 13.39: Illumina, Inc.: R&D Expenditure, 2017-2019
Figure 13.40: Illumina, Inc.: SWOT Analysis
Figure 13.41: Oxford Nanopore Technologies, Inc.: Product Portfolio
Figure 13.42: Oxford Nanopore Technologies, Inc.: SWOT Analysis
Figure 13.43: Pacific Biosciences of California, Inc.: Overall Product Portfolio
Figure 13.44: Pacific Biosciences of California, Inc.: Overall Financials, 2017-2019
Figure 13.45: Pacific Biosciences of California, Inc.: Revenue (by Segment), 2017-2019
Figure 13.46: Pacific Biosciences of California, Inc.: Revenue (by Region), 2017-2019
Figure 13.47: Pacific Biosciences of California, Inc.: R&D Expenditure, 2017-2019
Figure 13.48: Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 13.49: Partek Inc.: Product Portfolio
Figure 13.50: Partek Inc.: SWOT Analysis
Figure 13.51: QIAGEN N.V.: Product Portfolio
Figure 13.52: QIAGEN N.V.: Overall Financials, 2017-2019
Figure 13.53: QIAGEN N.V.: Revenue (by Segment), 2017-2019
Figure 13.54: QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 13.55: QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 13.56: QIAGEN N.V.: SWOT Analysis
Figure 13.57: SoftGenetics, LLC: Product Portfolio
Figure 13.58: SoftGenetics, LLC: SWOT Analysis
Figure 13.59: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 13.60: Thermo Fisher Scientific Inc.: Overall Financials: 2017-2020
Figure 13.61: Thermo Fisher Scientific Inc.: Sales (by Segment): 2017-2020
Figure 13.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 13.63: Thermo Fisher Scientific Inc.: R&D Expenditure, 2017-2019
Figure 13.64: Thermo Fisher Scientific Inc.: SWOT Analysis